NCT06004375View on ClinicalTrials.gov

THE EFFECT OF ARGININE AND GLUTAMINE ON COVID-19 PATIENTS OUTCOME: A RANDOMIZED CLINICAL TRIAL

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

May 30, 2023

Study Completion Date

May 30, 2023

Conditions
COVID-19
Interventions
DIETARY_SUPPLEMENT

Neomune

Neomune containing 4.8 g arginine and 2 g glutamine

Trial Locations (1)

25176

Dr. M. Djamil General Hospital, Padang

All Listed Sponsors
collaborator

M. Djamil General Hospital

UNKNOWN

lead

Universitas Sriwijaya

OTHER